The Department of Transportation confirmed today that as of July 17, only those who have received a booster dose of the COVID-19 vaccine can pass the testing requirements for domestic travel.
The COVID-19 Task Force has published a new set of regulations related to travel on all modes of transport, which will come into effect Next sunday. The key point in the regulations is that travelers who have received three doses of the COVID-19 vaccine are not required to submit a negative PCR or antigen test result prior to departure. Currently, travelers who have received at least two doses of the COVID-19 test are exempt from testing.
Children ages 6 to 17, an age group that is not currently eligible for booster shots, are exempt from testing if they have received two doses of the COVID-19 vaccine.
Children under the age of 6, who are not yet eligible to receive any COVID-19 vaccines, are exempt from all testing requirements but must be under the constant supervision of their parents during the flight.
Adults who have received two doses of the COVID-19 vaccine must submit a negative antigen test result obtained within one day of departure, or a negative PCR test result obtained within three days of departure.
Those taking a single dose must submit a negative PCR test result obtained within three days of departure.
Unvaccinated persons may only travel if they obtain a medical note exempting them from COVID-19 vaccines, as well as a negative PCR result obtained within three days of departure.
There have been no updates to the international travel rules yet. Under the latest set of regulations from the COVID-19 Task Force on International Arrivals published in May, those who have received at least two doses of the COVID-19 vaccine and do not show symptoms related to the disease upon arrival may skip all testing requirements.
Indonesia has tightened movement restrictions amid a steady increase in new COVID-19 infections in recent weeks. The country is expected to see a significant increase in infections in the third week of July due to the prevalence of Omicron BA.4 and BA.5 sub variants.